A study for healthy persons between the ages of 50 and 59 to evaluate the investigational use of an approved vaccine to prevent shingles, which is also known as herpes zoster, or zoster.
A research study for an investigational oral medication. You may qualify for this study if you:
The Rheos Pivotal Trial is testing the efficacy of an implantable electronic device to lower blood pressure. The power pack is inserted much like a pacemaker. Two leads, one to each carotid sinus then sends electrical impulses to the baroreceptors located within the sinus. The brain interprets these signals as an exceedingly high blood pressure and activates the bodies normal modulating mechanisms to reduce the pressure. In essence, it "tricks" the brain into lowering blood pressure. To qualify for this study, you must:
For more information about these trials, or if you are interested in participating, please contact Paula Smailes at 614-293-3644 or email at paula.smailes@osumc.edu.